MacroGenics Inc (MGNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9704 MEDICAL CENTER DRIVE ROCKVILLE, MD 20850

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Data as of 2021-09-19 12:43:33 -0400
Market Cap1.251 Billion Shares Outstanding61.107 Million Avg 30-day Volume1.097 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.21 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.19576 52-week High/Low36.48 / 18.16 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -40.3875
Data provided by IEX Cloud
View SEC Filings from MGNX instead.

View recent insider trading info

Funds Holding MGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MGNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

600 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIOTECH TARGET N V

BB BIOTECH AG

  • 10% Owner
6,875,564 2021-09-16 4

SPITZNAGEL THOMAS SR VP, BPD & MANUFACTURING

  • Officer
37,147 2021-07-16 3

BONVINI EZIO SR VP, RESEARCH & CSO

  • Officer
174,369 2021-06-24 4

O'BRIEN FEDERICA F.

  • Director
15,000 2021-05-13 3

STUMP DAVID C

  • Director
15,000 2021-05-13 1

HURWITZ EDWARD

  • Director
15,000 2021-05-13 1

COSTA PAULO F

  • Director
15,000 2021-05-13 1

JACKSON SCOTT THOMAS

  • Director
15,000 2021-05-13 1

GALBRAITH KENNETH

  • Director
15,000 2021-05-13 1

FERRANTE KAREN JEAN

  • Director
15,000 2021-05-13 1

SIEGEL JAY PHILIP

  • Director
15,000 2021-05-13 1

KARRELS JAMES SVP, CFO AND SECRETARY

  • Officer
143,460 2021-03-22 3

PETERS JEFFREY STUART GENERAL COUNSEL

  • Officer
65,251 2021-03-08 2

CILINSKI LYNN VP, CONTROLLER AND TREASURER

  • Officer
40,000 2021-02-22 1

KOENIG SCOTT PRESIDENT AND CEO

  • Officer
  • Director
280,000 2021-02-22 1

RISSER ERIC BLASIUS SR VP & CHIEF BUSINESS OFFICER

  • Officer
95,000 2021-02-22 5

ECK STEPHEN L. CHIEF MEDICAL OFFICER

  • Officer
60,000 2021-02-22 1

WIGGINTON JON MARC SR VP, CLINICAL DEV. & CMO

  • Officer
0 2020-02-20 0

FUST MATTHEW K

  • Director
0 2019-05-16 0

SARAN ATUL SVP & GENERAL COUNSEL

  • Officer
16,986 2017-04-28 0

STEIN KATHRYN E SVP, PRODUCT DEV. & REGULATORY

  • Officer
95,555 2016-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2021-09-20 12:21:46 -0400 2021-09-17 P 200,000 $19.93 a 6,875,564 direct 2.1216 2.1216 2 0.0 1

BIOTECH TARGET N V - > 10% Owner

BB BIOTECH AG - > 10% Owner

2021-09-20 12:21:46 -0400 2021-09-16 P 400,000 $20.94 a 6,675,564 direct 2.1216 2.1216 2 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MACROGENICS INC MGNX 2021-09-23 12:45:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 22:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 21:45:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 21:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 20:45:02 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 20:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 19:45:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 19:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 18:45:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 18:15:04 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 17:45:04 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 17:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 16:45:03 UTC -0.1804 0.2504 1700000
MACROGENICS INC MGNX 2021-09-22 16:15:03 UTC -0.1804 0.2504 1700000
MACROGENICS INC MGNX 2021-09-22 15:45:03 UTC -0.1804 0.2504 1700000
MACROGENICS INC MGNX 2021-09-22 15:15:03 UTC -0.1804 0.2504 1700000
MACROGENICS INC MGNX 2021-09-22 14:45:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 14:15:03 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 13:45:04 UTC -0.18 0.25 1700000
MACROGENICS INC MGNX 2021-09-22 13:15:03 UTC -0.18 0.25 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments